You need to register to attend

Course Information

Course Instructor

Author
 

Women in IBD 2023

FREE

Registration fee includes access to all educational sessions and food functions indicated on the agenda. Your personal data will be used to process your registration, support your experience on this website, and for other purposes described in our Privacy Policy.

 
Continue

Welcome and Introduction, Ryan Fitzpatrick, Joana Torres & Millie Long

Welcome and Introduction, Ryan Fitzpatrick, Joana Torres & Millie Long

Session I: Optimizing Biologic Therapies in IBD

Anti-TNF therapy in IBD (including biosimilars) Joana Torres, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
Anti-integrin therapy in IBD, Paula Ministro, Tondela-Viseu Hospital Center, Viseu, Portugall
IL-23 therapies in IBD, Triana Lobaton, Ghent University Hospital, Ghent, Belgium
S1 Panel Discussion

Session II: Focus on small molecules in IBD

Conventional immunomodulator therapy in IBD – still a role in the armamentarium?, Naila Arebi, St. Mark’s Hospital, Harrow, Middlesex, UK
JAK Inhibitors in IBD: Does selectivity matter?, Séverine Vermeire, Leuven, Belgium
S1P Inhibitors in IBD – how do they work and how to use them?, Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
S2 Panel Discussion
Independent discussion sponsored by Pfizer

Session III: Women’s health in IBD

Contraceptive and Pre-Conception Counseling in IBD: the role of the Gastroenterologist, Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
Pregnancy and IBD, Mette Julsgaard, Aarhus University Hospital, Aarhus, Denmark
Post Delivery: Implications for Mum and Baby, Sophie Restellini, Hôpital de La Tour, Switzerland
S3 Panel Discussion

Session IV: Medical and surgical management of IBD

Non-invasive monitoring of IBD, Federica Furfaro, IRCCS San Raffaele Hospital
Treat to Target in IBD – too much or too little?, Ana Guttierrez, Hospital General Universitario de Alicante
Surgical Management of the female IBD patient, Susana Ourô, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
S4 Panel Discussion

Session V: Lifespan of IBD

Successful Mentorship: A Guide for Mentees and Mentors, Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
A Pathway to Leadership for Women in GI: Lessons Learned, Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
Recognition of a Global Leader in IBD, Séverine Vermeire, Leuven, Belgium
S5 Panel Discussion

Session VI: Positioning of Therapies in IBD

Disease location and Severity: Considerations for Positioning of Therapies, Charlotte Hedin, Karolinska University Hospital in Stockholm, Sweden
Safety Considerations for Positioning of Therapies, Millie Long, University of North Carolina, Chapel Hill, North Carolina, USA
Management of Pouchitis in 2023: From Antibiotics to Biologics, Millie Long University of North Carolina, Chapel Hill, North Carolina, USA
S6 Panel Discussion
Independent Expert Discussion supported by Celltrion

Independent Expert Discussion supported by Celltrion

Considerations for the Management of Pediatric IBD, Lissy de Ridder, The Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
Sexuality in the IBD patient, Joana Roseira, Centro Hospitalar do Algarve, Portugal
Considerations for Management of IBD in Older Individuals, Daniela Pugliese, CEMAD – IBD UNIT Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy
S7 Panel Discussion

SANA Malhoa Hotel,
Lisboa, Portugal

It is our pleasure to invite you to participate in this one-of-a-kind event.

If you need additional information please contact us at: office@md-education.com

MD Education
4/4a Bloomsbury Square,
London, WC1A 2RP

MD Education USA LLC
4600 140th Avenue North Suite,
180 Clearwater, Florida 33762